Answer to Question 1
The scarred tissue of a cirrhotic liver impedes the flow of blood, three-fourths of which is supplied by the hepatic portal vein. The restricted blood flow within the liver stimulates the release of vasodilators (and therefore, increased blood flow) in nearby arterioles, leading to a greater volume of portal blood. The increased portal blood coupled with resistance to blood flow within the liver causes a rise in blood pressure within the hepatic portal vein, called portal hypertension. As portal pressure builds, some of these collaterals can become enlarged and engorged with blood, forming varices. The varices that develop in the esophagus and stomach are vulnerable to rupture because they have thin walls and often bulge into the lumen. If ruptured, they can cause massive bleeding that is sometimes fatal. The blood loss is exacerbated by the liver's reduced production of blood-clotting factors. Within 10 years of disease onset, about 50 percent of cirrhosis patients develop ascites, a large accumulation of fluid in the abdominal cavity. Ascites is primarily a consequence of portal hypertension, sodium and water retention in the kidneys, and reduced albumin synthesis in the diseased liver. As a result of portal hypertension, the distorted blood flow elsewhere in the body alters kidney function, leading to sodium and water retention and an accumulation of body fluid. The elevated pressure within the liver's small blood vessels causes fluid to leak into lymphatic vessels and, ultimately, the abdominal cavity. The movement of water into the abdomen is exacerbated by low levels of serum albumin, a protein that helps to retain fluid in blood vessels.
Answer to Question 2
D
An implantable cardiovert-defibrillator: A dual-chamber ICD device with a pulse generator is implant
Banding of an esophageal varix; A, varix; B, insertion of tube with O-ring; C, O-ring is placed arou
Stages of Hypertension
Drug Classes for Hypertension
Cirrhosis
Hepatic Portal Circulation